NYSE Drug Stocks to Watch: Pfizer Inc, Boston Scientific Corporation, Merck & Co, Health Management Associates Inc

Lakeway, TX -- (SBWIRE) -- 03/04/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Pfizer Inc.(NYSE:PFE) added 0.77% and is trading at $27.60. Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health and Consumer Healthcare, and Nutrition.

How Should Investors Trade PFE After The Recent Movement? Find Out Here

Boston Scientific Corporation(NYSE:BSX) is lower 0.68% and is trading at $7.32. Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions, Urology/Women’s Health, Neuromodulation, and Electrophysiology. In January 2011, it completed the acquisition of Intelect Medical, Inc.

Is BSX Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Merck & Co., Inc.(NYSE:MRK) is higher 1.27% and is trading at $43.17. Merck & Co., Inc. (Merck) is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company’s operations are principally managed on a products basis and consists of four segments: the Pharmaceutical, Animal Health, Consumer Care and Alliances segments, and one reportable segment: the Pharmaceutical segment.

Is MRK a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

Health Management Associates Inc(NYSE:HMA) is higher 1.28% and is trading at $11.04. Health Management Associates, Inc. by and through its subsidiaries operates general acute care hospitals and other health care facilities in non-urban communities.

How Should Investors Trade HMA After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.